NR1I2 and colonic neoplasm: Previous studies demonstrated that PXR protected human colon cancer cells from doxorubicin-induced apoptosis by downregulating pro-apoptotic genes20 and that activation of PXR promoted cell proliferation and migration in colon cancer cells, suggesting that PXR promotes the malignant phenotype in colon cancer.21